Dipeptidyl peptidase-4 inhibitor sitagliptin improves pancreatic β-cell function in hypertensive diabetic patients treated with angiotensin receptor blockers

Dipeptidyl peptidase-4 inhibitor sitagliptin improves pancreatic β-cell function in hypertensive diabetic patients treated with angiotensin receptor blockers

Introduction: Dipeptidyl peptidase (DPP)-4 inhibitors, a novel oral anti-diabetic agents, exert a protective effect on pancreatic β-cell function in patients with type 2 diabetic mellitus (T2DM). However, their beneficial effect in hypertensive T2DM patients treated with angiotensin receptor blocker...

Full description

Bibliographic Details
Main Authors: Kensuke Fukui, Hiroyuki Kawahito, Noriyuki Wakana, Masakazu Kikai, Kensuke Terada, Keita Yamamoto, Daisuke Irie, Taku Kato, Sonoko Miyagawa, Hiroyuki Yamada
Format: Article
Language:English
Published: Hindawi - SAGE Publishing 2015-12-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.1177/1470320315587180

Internet

https://doi.org/10.1177/1470320315587180

Similar Items